An inactive diphtheria toxin
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Diphtheria Toxoid from Corynebacterium diphtheriae

Item No. 23219

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formulation (Request formulation change)
Each vial, when reconstituted to 0.1 ml with water, contains 500 µg of diphtheria toxoid in 0.01 M sodium phosphate, pH 7.5, containing 0.1 mg/ml sorbitol
Shipping & Storage Information
Storage
2°C to 8°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $800

    Add
    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Diphtheria toxoid is formaldehyde inactivated form of diphtheria toxin that is non-specifically cross linked and subject to rearrangement.1 Formulations containing diphtheria toxoid have been used as adjuvents in vaccines to produce immunity to diphtheria, the disease caused by C. diphtheriae infection.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jiang, W., and Schwendeman, S.P. Formaldehyde-mediated aggregation of protein antigens: Comparison of untreated and formalinized model antigens. Biotechnol. Bioeng. 70(5), 507-517 (2000).

    2. Hansen, J., Zhang, L., Klein, N.P., et al. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine. Vaccine 35(49 Pt. B), 6879-6884 (2017).